BRCA1/BRCA2 Panel
- Specimen: 3 mL EDTA Whole Blood
- Turnaround time: 10–14 Business Days
- Target genes / antibodies: See factsheet
Price
$450
CLIA-certified molecular testing
Identifies pathogenic variants in BRCA1/BRCA2 genes associated with significantly elevated risk of breast, ovarian, and other cancers.
Clinical note: First-line when the family history points to HBOC.